ARYC volume increase on a great 8K.
$5M credit facility with expected $20M revenues, $2-3M earnings, $60-90M cap and NASDAQ listing.
ARYC is Extremely undervalued, currently at .0008. Market Cap of $620K. Trading at .25 x earnings! $2.3 million revenue last year and set to surpass that this year with a 2015 Q3 of $615K. Pleased DD ARYC and you will see:
Arrayit Corporation (ARYC) is the leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large scale analysis of genetic variation, biological function and diagnostics. Using Arrayit’s proprietary and patented technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for manufacturing molecular diagnostics.
Arrayit has earned respect as a leader in the health care and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. As a result, Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
